Kimberly-Clark Completes $48.7 Billion Acquisition of Kenvue
Kimberly-Clark (KMB) has officially closed its acquisition of consumer healthcare company Kenvue, a deal valued at approximately $48.7 billion in enterprise value. The merger combines Kimberly-Clark's hygiene brands like Huggies and Kleenex with Kenvue’s iconic health products such as Tylenol and Listerine, creating a dominant global leader in the health and hygiene sector with ten $10-billion-plus brands. The transaction was structured as a mix of cash and stock, resulting in an ownership split where existing Kimberly-Clark investors hold roughly 54% of the combined entity. To fund the acquisition, Kimberly-Clark utilized a $4.9 billion senior notes flotation and sold a 51% stake in its consumer paper and B2B hygiene business to Suzano (SUZ). The companies aim to realize $2.1 billion in annual run-rate synergies within three years.